44 related articles for article (PubMed ID: 9465500)
1. Epidemiology of Helicobacter in Chinese families: a foundation for cost-effective eradication strategies?
Marshall B
Gut; 2024 Apr; 73(5):870-871. PubMed ID: 36990678
[No Abstract] [Full Text] [Related]
2. Helicobacter pylori infection in India from a western perspective.
Thirumurthi S; Graham DY
Indian J Med Res; 2012 Oct; 136(4):549-62. PubMed ID: 23168695
[TBL] [Abstract][Full Text] [Related]
3. Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer.
Tavakoli M; Prach AT; Malek M; Hopwood D; Senior BW; Murray FE
Pharmacoeconomics; 1999 Oct; 16(4):355-65. PubMed ID: 10623364
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of Helicobacter pylori eradication for the treatment of duodenal ulcer disease in Japan: a decision analysis to assess eradication strategy in comparison with a conventional strategy.
Habu Y; Inokuchi H; Kiyota K; Hayashi K; Watanabe Y; Kawai K; Stålhammar NO
J Gastroenterol Hepatol; 1998 Mar; 13(3):280-7. PubMed ID: 9570241
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
Vakil N; Fennerty MB
Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
[TBL] [Abstract][Full Text] [Related]
6. A cost analysis of alternative treatments for duodenal ulcer.
Imperiale TF; Speroff T; Cebul RD; McCullough AJ
Ann Intern Med; 1995 Nov; 123(9):665-72. PubMed ID: 7574221
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen.
Catalano F; Branciforte G; Catanzaro R; Cipolla R; Bentivegna C; Brogna A
Aliment Pharmacol Ther; 2000 Oct; 14(10):1329-34. PubMed ID: 11012478
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of Helicobacter pylori eradication in India: to live and let live ... expensively?
Bhatia SJ; Kulkarni SG
Indian J Gastroenterol; 1997 Nov; 16 Suppl 1():S25-8. PubMed ID: 9465500
[No Abstract] [Full Text] [Related]
9. H2-receptor antagonists an Helicobacter pylori eradication.
Lamers CB
Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
[TBL] [Abstract][Full Text] [Related]
10. The economics of eradicating Helicobacter pylori infection in duodenal ulcer disease.
Vakil N; Fennerty B
Am J Med; 1996 May; 100(5A):60S-63S; discussion 63S-64S. PubMed ID: 8644784
[TBL] [Abstract][Full Text] [Related]
11. Evolving therapy for Helicobacter pylori infection: efficacy and economic impact in the treatment of patients with duodenal ulcer disease.
Cutler AF; Vakil N
Am J Manag Care; 1997 Oct; 3(10):1528-34. PubMed ID: 10178459
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori recolonization and ulcer relapse after its eradication in India.
Jain AK; Dayal VM
Indian J Gastroenterol; 1997 Nov; 16 Suppl 1():S22-4. PubMed ID: 9465499
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
